series-a
Stage
2018
Founded
2
Investors
About
Cellevate develops nanofiber-based cell culture systems for biopharmaceutical applications, offering tools for cell and gene therapy production and vaccine manufacturing through proprietary Cellevat3d™ technology.
Explore Cellevate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.